Nuñez, Baby Boy B.

HRN: 24-19-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/13/2023
12/20/2023
IV
LD 38 Mg, Maintain At 19mg
Q8
T/c Neonatal Sepsis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: